Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life?

European Journal of Endocrinology

Volumn 155, Issue 1, 2006, Pages 109-119

  Kołtowska Häggström, Maria ^a,b   Mattsson, Anders F ^a   Monson, John P ^c   Kind, Paul ^d   Badia, Xavier ^e   Casanueva, Felipe F ^f   Busschbach, Jan ^g   Koppeschaar, Hans P F ^h   Johannsson, Gudmundur ⁱ  

^a PFIZER INC   (United States)

^b UPPSALA UNIVERSITY   (Sweden)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF YORK   (United Kingdom)

^e Health Outcomes Research Europe   (Spain)

^f UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^g ERASMUS MEDICAL CENTER   (Netherlands)

^h Documentary Photography Department Utrecht Art Academy   (Netherlands)

ⁱ SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DATA BASE; FATIGUE; FEMALE; FOLLOW UP; GENDER; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPOPITUITARISM; LONG TERM CARE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEMORY; NETHERLANDS; PRIORITY JOURNAL; QUALITY OF LIFE; SELF ESTEEM; SOCIALIZATION; SPAIN; SWEDEN; UNITED KINGDOM;

ADULT; AGE OF ONSET; AGED; CLUSTER ANALYSIS; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; FEMALE; GEOGRAPHY; GREAT BRITAIN; GROWTH HORMONE; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; LONG-TERM CARE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NETHERLANDS; QUALITY OF LIFE; SPAIN; SWEDEN;

EID: 33746377019     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02176     Document Type: Article

References (36)

1. Carroll PV, Christ ER, Bengtsson B-Å, Carlsson L, Christiansen JS, Clemmons D, Hintz R, Ho K, Laron Z, Sizonenko P, Sönksen PH, Tanaka T, Thorner M and the members of Growth Hormone Research Society Scientific Committee. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Journal of Clinical Endocrinology and Metabolism 1998 83 382-395.
2. Raben AS. Clinical use of human growth hormone. New England Journal of Medicine 1962 266 82-86.
3. Deijen JB & van der Veen EA. The influence of growth hormone (GH) deficiency and GH replacement on quality of life in GH-deficient patients. Journal of Endocrinological Investigation 1999 22 127-136.
4. Radcliffe DJ, Pliskin JS, Silvers JB & Cuttler L. Growth hormone therapy and quality of life in adults and children. Pharmacoeconomics 2004 22 499-524.
5. Mårdh G, Lundin K, Borg G, Jonsson B & Lindeberg A. Growth hormone repalcement therapy in adult hypopituitary patients with growth hormone deficiency: combined data from 12 European placebo-controlled clinical trials. Endocrinology and Metabolism 1994 1 (Suppl A) 43-49.
6. Holmes SJ, McKenna SP, Doward LD, Hunt SM & Shalet SM. Development of a questionnaire to assess the QoL of adults with GHD. Endocrinology and Metabolism 1995 2 63-69.
7. Murray RD, Skillicorn CJ, Howell SJ, Lissett CA, Rahim A & Shalet SM. Dose titration and patient selection increases the efficacy of GH replacement in severely GH deficient adults. Clinical Endocrinology 1999 50 749-757.
8. Li Voon Chong JSW, Benbow S, Foy P, Wallymahmed ME, Wile D & MacFarlane IA. Elderly people with hypothalamic-pituitary disease and untreated GH deficiency: lipid profiles, body composition and quality of life compared with control subjects. Clinical Endocrinology 2000 53 551-559.
9. Gilchrist FJ, Murray RD & Shalet SM. The effect of long-term untreated growth hormone deficiency and 9 years of GH replacement on the quality of life (QoL) of GH-deficient adults. Clinical Endocrinology 2002 57 363-370.
10. Rosén T, Wirén L, Wilhelmsen L, Wiklund I & Bengtson BÅ. Decreased psychological well-being in adult patients with growth hormone deficiency. Clinical Endocrinology 1994 40 111-116.
11. Stabler B. Impact of growth hormone (GH) therapy on quality of life along the lifespan of GH-treated patients. Hormone Research 2001 56 55-58.
12. Cuneo R, Judd S, Wallace JD, Perry-Keene D, Burger H, Lim-Tio S, Strauss B, Stockigt J, Topliss D, Alford F, Hew L, Bode H, Conway A, Handelsman D, Dunn S, Boyages S, Wah Cheung N & Hurley D. The Australian multicenter trial of growth hormone (GH) treatment in GH-deficient adults. Journal of Clinical Endocrinology and Metabalism 1998 83 107-116.
13. Baum HBA, Katznelson L, Sherman JC, Biller BMK, Hayden DL, Schoenfeld DA, Cannistraro KE & Klibanski A. Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficit. Journal of Clinical Endocrinology and Metabolism 1998 83 3184-3189.
14. Arwert LI, Roost JC, Lips P, Twisk JWR, Manoliut RA & Drent ML. Effects of 10 years of GH replacement therapy in adult GH-deficient men. Clinical Endocrinology 2005 63 310-316.
15. McGauley GA, Cuneo R, Salomon F & Sönksen PH. Psychological well-being before and after growth hormone treatment in adults with growth hormone deficiency. Hormone Research 1990 33 52-54.
16. Bengtsson B-Å, Eden S, Lönin L, Kvist H, Stokland A, Lindstedt G, Bosaeus I, Tölli J, Sjöström L & Isaksson OGP. Treatment of adults with GHD with recombinant human GH. Journal of Clinical Endocrinology and Metabolism 1993 76 309-317.
17. Burman P, Broman JE, Hetta J, Wiklund I, Erfurth EM, Hagg E & Karlsson FA. QoL in adults with GHD: response to treatment with recombinant human GH in a placebo-controlled 21-month trial. Journal of Clinical Endocrinology and Metabolism 1995 80 3585-3590.
18. Arwert LI, Deijen JB, Witlox J & Drent ML. The influence of growth hormone (GH) substitution on patient-reported outcomes and cognitive functions in GH-deficient patients: a meta-analysis. Growth Hormone and IGF Research 2005 15 47-54.
19. Malik IA, Foy P, Wallymahmed M, Wilding JPH & MacFarlane IA. Assessment of quality of life in adults receiving long-term growth hormone replacement compared to control subjects. Clinical Endocrinology 2003 59 75-81.
20. Rosilio M, Blum WF, Edwards DJ, Shavrikova EP, Valle D, Lamberts SWJ, Erfurth EM, Webb SM, Ross RJ, Chihara K, Henrich G, Herschbach P & Attanasio AF. Long-term improvement of quality of life during growth hormone (GH) replacement therapy in adults with GH deficiency, as measured by questions on Life Satisfaction-Hypopituitarism (QLS-H). Journal of Clinical Endocrinology and Metabolism 2004 89 1684-1693.
21. Eiser C, Vance YH, Glaser H, Horne B, Picton S, Stoner A & Butler G. Growth hormone treatment and quality of life among survivors of childhood cancer. Hormone Research 2005 63 300-304.
22. Inglehart R & Jacques-Rene R. Aspirations adapt to situations - but why are the Belgians so much happier than the French? A cross-cultural analysis of the subjective quality of life. In Research on the Quality of Life, pp 1-56. Ed. FM Andrews, Ann Arbor: Institute for Social Research, University of Michigan, 1986.
23. Mukherjee A, Tolhurst-Cleaver S, Ryder WDJ, Smethurst L & Shalet SM. The characteristics of quality of life impairment in adult growth hormone deficient survivors of cancer and their response to GH replacement therapy. Journal of Clinical Endocrinology and Metabolism 2005 90 1542-1549.
24. Hunt SM & McKenna SP. The QLDS: a scale for the measurement of quality of life in depression. Health Policy 1992 22 307-319.
25. McKenna SP, Doward LC, Alonso J, Kohlmann T, Niero M, Prieto L & Wirén L. The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency. Quality of Life Research 1999 8 373-383.
26. Wirén L, Whalley D, McKenna SP & Wilhelmsen L. Application of a disease-specific, quality-of-life measure (QoL-AGHDA) in growth hormone-deficient adults and a random population sample in Sweden: validation of the measure by Rasch analysis. Clinical Endocrinology 2000 52 143-152.
27. Monson JP. KIMS: Treating adult GH deficiency. The Endocrinologist 2003 68 10.
28. Koltowska-Haggstrom M, Hennessy S, Mattsson AF, Monson JP & Kind P. Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA): comparison of normative reference data for the general population of England and Wales with results for adult hypopituitary patients with growth hormone deficiency. Hormone Research 2005 64 46-54.
29. Badia X, Lucas A, Sanmarti A, Roset M & Ullied A. One-year follow-up of quality of life in adults with untreated growth hormone deficiency. Clinical Endocrinology 1998 49 765-771.
30. Page RC, Hammersley MS, Burke CW & Wass JA. An account of the quality of life of patients after treatment for non-functioning pituitary tumours. Clinical Endocrinology 1997 46 401-406.
31. Wallymahmed ME, Foy P & MacFarlane IA. The quality of life of adults with growth hormone deficiency: comparison with diabetic patients and control subjects. Clinical Endocrinology 1999 51 333-338.
32. Sandberg DE, MacGillivray MH, Clopper RR, Fung C, LeRoux L & Alliger DE. Quality of life among formerly treated childhood-onset growth hormone deficient adults: a comparison with unaffected siblings. Journal of Clinical Endocrinology and Metabolism 1998 83 (Suppl 4) 1134-1142.
33. Black N. What observational studies can offer decision makers? Hormone Research 1999 51 (Suppl 1) 44-49.
34. Kahn MG. Clinical research databases and clinical decision making in chronic diseases. Hormone Research 1999 51 (Suppl 1) 50-57.
35. Verhelst J, Kendall-Taylor P, Erfurth E-M, Price DA, Geffner M, Koltowska-Häggström M, Jönsson PJ, Wilton P & Abs R. Baseline characteristics and response to 2 years of growth hormone replacement of hypopituitary patients with growth hormone deficiency due to adult-onset craniopharyngioma in comparison to patients with non-functioning pituitary adenoma: data from KIMS (Pfizer International Metabolic Database). The Journal of Clinical Endocrinology and Metabolism 2005 90 (Suppl 8) 4636-4643.
36. Wirén L, Bengtsson B-Å & Johannsson G. Beneficial effects of long-term GH replacement therapy on quality of life in adults with GH deficiency. Clinical Endocrinology 1998 48 613-620.